| Sami Muhammad Khan, DO | |
|
2800 Maple Ave, Zanesville, OH 43701-1716 | |
| (772) 574-0453 | |
| Not Available |
| Full Name | Sami Muhammad Khan |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2800 Maple Ave, Zanesville, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467816884 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34.013290 (Ohio) | Primary |
| Entity Name | Central Ohio Hospitalists, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659455145 PECOS PAC ID: 7810985686 Enrollment ID: O20040503000515 |
News Archive
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.
The research contradicts the results of a recent study, which found affected fathers were more likely than affected mothers to transmit the risk of developing MS to their children.
Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers.
In this Huffington Post opinion piece, Serra Sippel, president of the Center for Health and Gender Equity, writes, "In 2012, there is a presidency at stake - so what does that mean for women's health and rights in the coming year? How will political posturing and the race for votes affect what really matters?"
On the European Antibiotic Awareness Day, researchers announce the results of a pilot study completed in record time. The initiative opens new perspectives for the control of bacterial infections in Portuguese hospitals.
› Verified 4 days ago
| Entity Name | Pai Participant 1 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093371312 PECOS PAC ID: 8123351954 Enrollment ID: O20200402000312 |
News Archive
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.
The research contradicts the results of a recent study, which found affected fathers were more likely than affected mothers to transmit the risk of developing MS to their children.
Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers.
In this Huffington Post opinion piece, Serra Sippel, president of the Center for Health and Gender Equity, writes, "In 2012, there is a presidency at stake - so what does that mean for women's health and rights in the coming year? How will political posturing and the race for votes affect what really matters?"
On the European Antibiotic Awareness Day, researchers announce the results of a pilot study completed in record time. The initiative opens new perspectives for the control of bacterial infections in Portuguese hospitals.
› Verified 4 days ago
| Entity Name | Mercy Health Physicians Springfield Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427679067 PECOS PAC ID: 7315361359 Enrollment ID: O20200722003840 |
News Archive
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.
The research contradicts the results of a recent study, which found affected fathers were more likely than affected mothers to transmit the risk of developing MS to their children.
Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers.
In this Huffington Post opinion piece, Serra Sippel, president of the Center for Health and Gender Equity, writes, "In 2012, there is a presidency at stake - so what does that mean for women's health and rights in the coming year? How will political posturing and the race for votes affect what really matters?"
On the European Antibiotic Awareness Day, researchers announce the results of a pilot study completed in record time. The initiative opens new perspectives for the control of bacterial infections in Portuguese hospitals.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sami Muhammad Khan, DO 2800 Maple Ave, Zanesville, OH 43701-1716 Ph: (740) 453-7725 | Sami Muhammad Khan, DO 2800 Maple Ave, Zanesville, OH 43701-1716 Ph: (772) 574-0453 |
News Archive
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.
The research contradicts the results of a recent study, which found affected fathers were more likely than affected mothers to transmit the risk of developing MS to their children.
Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers.
In this Huffington Post opinion piece, Serra Sippel, president of the Center for Health and Gender Equity, writes, "In 2012, there is a presidency at stake - so what does that mean for women's health and rights in the coming year? How will political posturing and the race for votes affect what really matters?"
On the European Antibiotic Awareness Day, researchers announce the results of a pilot study completed in record time. The initiative opens new perspectives for the control of bacterial infections in Portuguese hospitals.
› Verified 4 days ago
Dr. Ronald J Kalchik, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 N Maysville Ave, Zanesville, OH 43701 Phone: 740-455-3112 Fax: 740-455-1363 | |
Shelly L Dunmyer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3620 Court Dr, Zanesville, OH 43701 Phone: 740-454-1248 Fax: 740-342-6702 | |
Dr. Walter Wielkiewicz, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 751 Forest Ave Ste 402, Zanesville, OH 43701 Phone: 740-454-0196 | |
Dr. Lisa Flarey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Adair Ave, Zanesville, OH 43701 Phone: 740-452-7818 | |
Dr. Douglas Myers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4063 N Pointe Dr, Suite B, Zanesville, OH 43701 Phone: 740-452-1905 Fax: 740-452-4117 | |
Maria S Jamiolkowski, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr, Suite 110, Zanesville, OH 43701 Phone: 740-450-4271 Fax: 740-450-4286 | |
Alexandrea Lyn Johnson, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 945 Bethesda Dr, Zanesville, OH 43701 Phone: 740-455-4915 |